UBS Group »

Trinity Biotech shares owned by UBS Group

Quarter-by-quarter ownership of Trinity Biotech shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Trinity Biotech

Tip: Access up to 7 years of quarterly data

All positions including Trinity Biotech held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trinity Biotech by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $7 17 0.41
2023-09-30 $104 142 0.73
2023-03-31 $11k 12k 0.94
2022-12-31 $466 471 0.99
2022-09-30 $10k 9.5k 1.06
2022-03-31 $999 701 1.43
2021-12-31 $0 6.4k 0.00
2021-09-30 $0 605 0.00
2021-06-30 $9.0k 3.2k 2.82
2021-03-31 $2.0k 555 3.60
2020-12-31 $5.0k 1.3k 3.89
2020-03-31 $17k 15k 1.12
2019-12-31 $4.0k 4.1k 0.96
2019-06-30 $1.0k 408 2.45
2018-09-30 $2.0k 567 3.53
2018-03-31 $6.0k 1.1k 5.25
2017-12-31 $999 271 3.69
2017-03-31 $13k 2.1k 6.09
2016-12-31 $5.0k 769 6.50
2016-06-30 $7.0k 609 11.49
2016-03-31 $31k 2.3k 13.33
2015-12-31 $4.0k 300 13.33
2015-09-30 $19k 1.7k 11.42
2015-03-31 $52k 2.7k 19.65

Top funds holding Trinity Biotech